Modern approach to infusion therapy of pregnant women with gestational hypertension

To date, there are no effective treatment for placental dysfunction in pregnant women with gestational hypertension. Therefore, the purpose of our study was to investigate the clinical efficacy of proposed method of infusion therapy for pregnant women with gestational hypertension, which included a...

Full description

Saved in:
Bibliographic Details
Main Authors: O.V. Vaskiv, A.P. Grigorenko, O.G. Gorbatyuk, A.S. Shatkovska, A.M. Binkovska, I.A. Priymak
Format: Article
Language:English
Published: Dnipro State Medical University 2023-03-01
Series:Medičnì Perspektivi
Subjects:
Online Access:http://journals.uran.ua/index.php/2307-0404/article/view/276021
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841562960487514112
author O.V. Vaskiv
A.P. Grigorenko
O.G. Gorbatyuk
A.S. Shatkovska
A.M. Binkovska
I.A. Priymak
author_facet O.V. Vaskiv
A.P. Grigorenko
O.G. Gorbatyuk
A.S. Shatkovska
A.M. Binkovska
I.A. Priymak
author_sort O.V. Vaskiv
collection DOAJ
description To date, there are no effective treatment for placental dysfunction in pregnant women with gestational hypertension. Therefore, the purpose of our study was to investigate the clinical efficacy of proposed method of infusion therapy for pregnant women with gestational hypertension, which included a complex of drugs: pentoxifylline, arginine hydrochloride with levocarnitine and rheosorbilact. We observed 73 pregnant women with single fetation, starting from 28 weeks of gestation, who were observed before and during childbirth, and in the postpartum period by the time of discharge from the hospital. All examined women were divided into 3 groups. The first group included 30 pregnant women with gestational hypertension, who received (along with the basic therapy of methyldopa drugs) a complex of infusion solutions: pentoxifylline 0.05% – 100 ml; solution containing arginine hydrochloride 4.2% and levocarnitine 2.0% – 100 ml; reosorbilact preparation – 100 ml. The infusion was carried out once a day in the specified sequence for 10 days. The second group included 20 patients with gestational hypertension on basic therapy with methuldopa only. The control group included 23 women with physiological pregnancy. The data of our study show that in patients receiving the proposed infusion therapy there was a significant decrease in the development of placental dysfunction by 38.3%, the threat of premature birth – by 18.3% and fetal distress – by 30.0%, premature rupture of the membranes – by 35.0%, weakness of labor – by 28.3%, a decrease in the risk of perinatal central nervous system damage – by 33.3% and the frequency of cephalohematomas – by 30.0% compared with women who received only antihypertensive therapy.
format Article
id doaj-art-ea1423e07d0a451db6d47537ac347485
institution Kabale University
issn 2307-0404
language English
publishDate 2023-03-01
publisher Dnipro State Medical University
record_format Article
series Medičnì Perspektivi
spelling doaj-art-ea1423e07d0a451db6d47537ac3474852025-01-03T00:37:43ZengDnipro State Medical UniversityMedičnì Perspektivi2307-04042023-03-0128110411010.26641/2307-0404.2023.1.276021314186Modern approach to infusion therapy of pregnant women with gestational hypertensionO.V. Vaskiv0https://orcid.org/0000-0001-6310-5692A.P. Grigorenko1https://orcid.org/0000-0003-3184-5359O.G. Gorbatyuk2https://orcid.org/0000-0002-0123-367XA.S. Shatkovska3https://orcid.org/0000-0002-3638-8882A.M. Binkovska4https://orcid.org/0000-0002-6718-4882I.A. Priymak5https://orcid.org/0000-0001-9933-3371Vinnytsia National Pirogov Memorial Medical University, Ivan Puliuy str., 6, Khmelnytskyi, 29016Vinnytsia National Pirogov Memorial Medical University, Ivan Puliuy str., 6, Khmelnytskyi, 29016Vinnytsia National Pirogov Memorial Medical University, Ivan Puliuy str., 6, Khmelnytskyi, 29016Vinnytsia National Pirogov Memorial Medical University, Ivan Puliuy str., 6, Khmelnytskyi, 29016Vinnytsia National Pirogov Memorial Medical University, Ivan Puliuy str., 6, Khmelnytskyi, 29016Vinnytsia National Pirogov Memorial Medical University, Ivan Puliuy str., 6, Khmelnytskyi, 29016To date, there are no effective treatment for placental dysfunction in pregnant women with gestational hypertension. Therefore, the purpose of our study was to investigate the clinical efficacy of proposed method of infusion therapy for pregnant women with gestational hypertension, which included a complex of drugs: pentoxifylline, arginine hydrochloride with levocarnitine and rheosorbilact. We observed 73 pregnant women with single fetation, starting from 28 weeks of gestation, who were observed before and during childbirth, and in the postpartum period by the time of discharge from the hospital. All examined women were divided into 3 groups. The first group included 30 pregnant women with gestational hypertension, who received (along with the basic therapy of methyldopa drugs) a complex of infusion solutions: pentoxifylline 0.05% – 100 ml; solution containing arginine hydrochloride 4.2% and levocarnitine 2.0% – 100 ml; reosorbilact preparation – 100 ml. The infusion was carried out once a day in the specified sequence for 10 days. The second group included 20 patients with gestational hypertension on basic therapy with methuldopa only. The control group included 23 women with physiological pregnancy. The data of our study show that in patients receiving the proposed infusion therapy there was a significant decrease in the development of placental dysfunction by 38.3%, the threat of premature birth – by 18.3% and fetal distress – by 30.0%, premature rupture of the membranes – by 35.0%, weakness of labor – by 28.3%, a decrease in the risk of perinatal central nervous system damage – by 33.3% and the frequency of cephalohematomas – by 30.0% compared with women who received only antihypertensive therapy.http://journals.uran.ua/index.php/2307-0404/article/view/276021fetoplacental dysfunctiongestational hypertensiontreatment
spellingShingle O.V. Vaskiv
A.P. Grigorenko
O.G. Gorbatyuk
A.S. Shatkovska
A.M. Binkovska
I.A. Priymak
Modern approach to infusion therapy of pregnant women with gestational hypertension
Medičnì Perspektivi
fetoplacental dysfunction
gestational hypertension
treatment
title Modern approach to infusion therapy of pregnant women with gestational hypertension
title_full Modern approach to infusion therapy of pregnant women with gestational hypertension
title_fullStr Modern approach to infusion therapy of pregnant women with gestational hypertension
title_full_unstemmed Modern approach to infusion therapy of pregnant women with gestational hypertension
title_short Modern approach to infusion therapy of pregnant women with gestational hypertension
title_sort modern approach to infusion therapy of pregnant women with gestational hypertension
topic fetoplacental dysfunction
gestational hypertension
treatment
url http://journals.uran.ua/index.php/2307-0404/article/view/276021
work_keys_str_mv AT ovvaskiv modernapproachtoinfusiontherapyofpregnantwomenwithgestationalhypertension
AT apgrigorenko modernapproachtoinfusiontherapyofpregnantwomenwithgestationalhypertension
AT oggorbatyuk modernapproachtoinfusiontherapyofpregnantwomenwithgestationalhypertension
AT asshatkovska modernapproachtoinfusiontherapyofpregnantwomenwithgestationalhypertension
AT ambinkovska modernapproachtoinfusiontherapyofpregnantwomenwithgestationalhypertension
AT iapriymak modernapproachtoinfusiontherapyofpregnantwomenwithgestationalhypertension